UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under
Section 12(g) of the Securities Exchange Act of 1934 or Suspension
of Duty to File Reports Under Sections 13 and 15(d) of the
Securities Exchange Act of 1934.
Commission File Number 0-20346
MICROTEK MEDICAL,INC.
(Exact name of registrant as specified in its charter)
512 LEHMBERG ROAD, COLUMBUS, MISSISSIPPI 39703
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Registrant's telephone number, including area code:
(601) 327-1863
Common Stock, $.01 par value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file
reports.
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [ ]
Approximate number of holders of record as of the
certification or notice date: one
Microtek Medical, Inc. merged into, and became a wholly-owned
subsidiary of, Isolyser Company, Inc., effective as
of August 30, 1996
Pursuant to the requirements of the Securities Exchange Act of
1934 Microtek Medical, Inc. has caused this certification/notice to
be signed on its behalf by the undersigned duly authorized person.
MICROTEK MEDICAL, INC.
DATE: August 30, 1996 By: Kimber L. Vought
__________________________
Kimber L. Vought,
President and
Chief Executive Officer
